AI-generated summary
In this mouse study, the authors co-injected donor T cells with T cell-depleted bone marrow into fetal mice to improve engraftment. Donor T cells alone with marrow produced multilineage engraftment (median 68.3%) but severe graft-versus-host disease, and treating the T cells with a light-based therapy reduced disease while also reducing engraftment. Sensitized, light-treated T cells partially restored engraftment with little disease.
- Who or what was studied
- Fetal mice (BALB/c recipients, C57BL/6 donors)
- Limits stated in the abstract
- The study was conducted in fetal mice, so the findings may not apply to humans, and the abstract reports only small group sizes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on academic.oup.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Ultraviolet. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.